Other studies recommend the combined examination of CEA and CA15-3, as well as CEA and CA19-9, proving that the levels of these tumor markers are significantly elevated in malignant pleural effusions, but remain with a low sensitivity [35]. The gene discussed is CEACAM5; the disease is neoplasm.